Blueprint to reduce wasteful blood transfusions

(Johns Hopkins Medicine) By analyzing data from randomized clinical trials comparing blood transfusion approaches, Johns Hopkins experts, along with colleagues at Cleveland Clinic and NYU Langone Medical Center, endorse recommendations for blood transfusions that reduce blood use to improve patient safety and outcomes. Publishing this week in JAMA Internal Medicine, the report also provides a how-to guide for launching a patient blood management program.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news

Related Links:

Conditions:   Lymphoblastic Leukemia, Acute, Adult;   Ph Negative ALL;   Newly Diagnosed Intervention:   Drug: Blinatumomab Sponsors:   Institute of Hematology and Blood Transfusion, Czech Republic;   CZECRIN - Czech Clinical Research Infrastructure Network Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Acute Lymphoblastic Leukemia, Adult;   Ph+ ALL;   Newly Diagnosed Intervention:   Drug: Ponatinib 15 MG Oral Tablet Sponsors:   Institute of Hematology and Blood Transfusion, Czech Republic;   CZECRIN - Czech Clinical Research Infrastructure Network Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Lymphoblastic Leukemia, Acute, Adult;   Ph Negative ALL;   Newly Diagnosed Intervention:   Drug: Blinatumomab Sponsors:   Institute of Hematology and Blood Transfusion, Czech Republic;   CZECRIN - Czech Clinical Research Infrastructure Network Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Acute Lymphoblastic Leukemia, Adult;   Ph+ ALL;   Newly Diagnosed Intervention:   Drug: Ponatinib 15 MG Oral Tablet Sponsors:   Institute of Hematology and Blood Transfusion, Czech Republic;   CZECRIN - Czech Clinical Research Infrastructure Network Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Lymphoblastic Leukemia, Acute, Adult;   Ph Negative ALL;   Newly Diagnosed Intervention:   Drug: Blinatumomab Sponsors:   Institute of Hematology and Blood Transfusion, Czech Republic;   CZECRIN - Czech Clinical Research Infrastructure Network Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Acute Lymphoblastic Leukemia, Adult;   Ph+ ALL;   Newly Diagnosed Intervention:   Drug: Ponatinib 15 MG Oral Tablet Sponsors:   Institute of Hematology and Blood Transfusion, Czech Republic;   CZECRIN - Czech Clinical Research Infrastructure Network Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conclusions: Elderly patients who underwent LPD in this study had good overall outcomes after LPD that were similar to young patients. The perioperative and long-term outcomes of LPD are not worse. Rates of ICU admission and hospital stays increased in elderly patients undergoing LPD when compared with nonelderly ones. LPD can be performed on elderly patients with similar outcomes as younger patients; therefore, age itself should not be a contraindication for LPD for pancreatic cancer, but it suggests that elderly patients with comorbidities should be more stringently selected for surgery.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research
Background: Dengue is a vector-borne disease; however, non-vectorial transmission of dengue has been completely overlooked. As we know majority of Dengue infection is asymptomatic, however, during acute sub-clinical stage one might be infectious. One could also transmit the virus through blood transfusion at the time of acute asymptomatic stage during the early five days of viremia. We planned to estimate the burden of dengue in capital region of India.
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Tags: 0614 Source Type: research
Background: Since 2015, Zika virus (ZIKV) outbreaks have occurred in the Americas and the Pacific involving mosquito-borne and sexual transmission. ZIKV has also emerged as a risk to global blood transfusion safety. Aedes aegypti, a mosquito well established in north and some parts of central and southern Queensland, Australia, transmits ZIKV. Aedes albopictus, another potential ZIKV vector, is a threat to mainland Australia. Australia has not yet reported local transmission of ZIKV. However, due to the close proximity to, and frequent air traffic with many neighboring countries endemic for ZIKV, a history of imported case...
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Tags: 0582 Source Type: research
Conclusions: Robotic resection of postero-superior liver segments is feasible and safe and may have some advantages over laparoscopic and openapproaches. This video may help gastrointestinal surgeons perform this complex procedure.
Source: Journal of Gastrointestinal Surgery - Category: Surgery Source Type: research
More News: Blood Transusion | Clinical Trials | Internal Medicine | International Medicine & Public Health